Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Expert Review of Clinical Pharmacology · 2024
DOI: 10.1080/17512433.2024.2355270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2024. Verfasst von Emily G McDonald und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Polypharmacy, Deprescriptions, Inappropriate Prescribing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Production of this document has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent….
Themen: Medikationssicherheit
Abstract (Originalsprache)
INTRODUCTION: Over the past decade, polypharmacy has increased dramatically. Measurable harms include falls, fractures, cognitive impairment, and death. The associated costs are massive and contribute substantially to low-value health care. Deprescribing is a promising solution, but there are barriers. Establishing a network to address polypharmacy can help overcome barriers by connecting individuals with an interest and expertise in deprescribing and can act as an important source of motivation and resources. AREAS COVERED: Over the past decade, several deprescribing networks were launched to help tackle polypharmacy, with evidence of individual and collective impact. A network approach has several advantages; it can spark interest, ideas and enthusiasm through information sharing, meetings and conversations with the public, providers, and other key stakeholders. In this special report, the details of how four deprescribing networks were established across the globe are detailed. EXPERT OPINION: Networks create links between people who lead existing and/or budding deprescribing practices and policy initiatives, can influence people with a shared passion for deprescribing, and facilitate sharing of intellectual capital and tools to take initiatives further and strengthen impact.This report should inspire others to establish their own deprescribing networks, a critical step in accelerating a global deprescribing movement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
- Canadian Medication Appropriateness and Deprescribing Network, Montreal, Quebec, Canada.
- Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.
- Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Förderung
- Production of this document has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent…
Zitieren
APA
McDonald, E. G., Lundby, C., Thompson, W., Boyd, C., Farrell, B., Gagnon, C., Herbin, J., Khuong, N., Moriarty, F., Pierson, T., Scott, S., Scott, I. A., Silvius, J., Spinewine, A., Steinman, M. A., Tannenbaum, C., Trimble, J., Turner, J. P., & Reeve, E. (2024). Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2024.2355270
Vancouver
McDonald EG, Lundby C, Thompson W, Boyd C, Farrell B, Gagnon C, et al. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks. Expert Review of Clinical Pharmacology. 2024. doi:10.1080/17512433.2024.2355270
BibTeX
@article{McDonald2024,
author = {McDonald, Emily G and Lundby, Carina and Thompson, Wade and Boyd, Cynthia and Farrell, Barbara and Gagnon, Camille and Herbin, Jennie and Khuong, Ninh and Moriarty, Frank and Pierson, Tiphaine and Scott, Sion and Scott, Ian A and Silvius, Jim and Spinewine, Anne and Steinman, Michael A and Tannenbaum, Cara and Trimble, Johanna and Turner, Justin P and Reeve, Emily},
title = {Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks},
journal = {Expert Review of Clinical Pharmacology},
year = {2024},
doi = {10.1080/17512433.2024.2355270}
}
EUVIMED